• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Intensive systolic blood pressure reduction below 140 mmHg reduces risk of major cardiovascular events

byStefan Trela
November 11, 2015
in Cardiology, Chronic Disease
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

 

1. In this systematic review and meta-analysis of randomized controlled trials, more intensive treatment to lower systolic blood pressure below the currently recommended goal of 140 mmHg significantly reduced the risk of major cardiovascular events, myocardial infarction, stroke, retinopathy progression, and albuminuria, compared to less intensive treatment.

2. Trials in which all patients had vascular disease, renal disease, or diabetes showed the greatest benefit in intensive blood pressure reduction compared to other trials, and the overall effects of intensive treatment were consistent across all major patient subgroups.

Evidence Rating Level: 1 (Excellent)      

Study Rundown: Guidelines blood pressure goals in high-risk patient populations have changed over time, with recommendations to increase the target blood pressure for patients with cerebrovascular disease, coronary heart disease, renal disease and diabetes to 140/90 mmHg, and 150/90 mmHg for individuals over age 60. However, a significant number of blood pressure-attributable events occur in patients with a systolic blood pressure below 140 mmHg. This study conducted a systematic review of the literature to assess all trials comparing various blood pressure targets and specifically focus on the safety and efficacy of lowering systolic blood pressure below 140 mmHg in high-risk patients.

The results showed a mean blood pressure level at follow-up of 133/76 mmHg in the more intensive blood pressure treatment group compared to 140/81 mmHg in the less intensive treatment group. More intensive treatment significantly reduced the risk of major cardiovascular events, myocardial infarction, stroke, retinopathy progression, and albuminuria, compared to less intensive treatment. However, there was no significant reduction in the risk of heart failure, cardiovascular death, non-cardiovascular death, end-stage kidney disease, or total mortality. Additionally, trials in which all patients had vascular disease, renal disease, or diabetes showed the greatest benefit in intensive blood pressure reduction, and the overall effects of intensive treatment were consistent across all major patient subgroups. Severe hypotension was associated with more intensive treatment, but no significant serious adverse events were associated with blood pressure lowering in both treatment groups. This study was strengthened by including trials comparing different blood pressure targets and a variety of patient populations, but was limited in that individual participant data was unavailable to analyze treatment effects in various population groups.

Click to read the study in The Lancet

RELATED REPORTS

Radiofrequency renal denervation produces long-lasting reductions in blood pressure

Intensive blood pressure control associated with increased cerebral blood flow in patients with hypertension – the SPRINT trial

Isometric exercise training may be more effective  at blood pressure management than high intensity interval training

Relevant Reading: 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)

In-Depth [systematic review and meta-analysis]: 19 randomized controlled trials including 44,989 participants were analyzed for this study. 2,496 major cardiovascular events, 1,762 all-cause deaths, and 514 end-stage kidney disease events were observed during a mean follow-up of 3.8 years (range 1.0-8.4 years). The mean baseline blood pressure levels ranged from 123-172 mmHg systolic and 76-105 mmHg diastolic, with an overall mean of 159/92 mmHg. The mean follow-up blood pressure levels were 133/76 mmHg in the more intensive treatment groups and 140/81 mmHg in the less intensive treatment groups.

Intensive blood pressure lowering treatment compared to less intensive treatment reduced the risk of major cardiovascular events by 14% (95% CI 4-22), myocardial infarction by 13% (0-24), stroke by 22% (10-32), retinopathy progression by 19% (0-34), and albuminuria by 10% (3-16). However, no significant reduction was observed with more intensive treatment in reducing the risk of heart failure (Relative Risk [RR] 0.85, 95% CI 0.66-1.11), cardiovascular death (0.91, 0.74-1.11), non-cardiovascular death (0.98, 0.86-1.13), end-stage kidney disease (0.90, 0.77-1.06), or total mortality (0.91, 0.81-1.03). Trials in which all patients had vascular disease, renal disease, or diabetes had an average control group rate of major vascular events of 2.9% per year compared to 0.9% in other trials, resulting in a number needed to treat of 94 (95% CI 44-782), compared to 186 (107-708) in all other trials. Six trials reported serious adverse events, with five trials reporting an increased risk of severe hypotension with intensive treatment (61 events [0.3% event rate per person-year]) compared to less intensive treatment (23 events [0.1%]; p=0.015), but there were no significant serious adverse events associated with blood pressure lowering (280 events [1.2%] vs. 211 events [0.9%], p=0.112).

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: blood pressure
Previous Post

Long-term safety of silicone gel breast implants is unclear

Next Post

Clinically undetected myocardial scars detected by cardiac MRI

RelatedReports

Tenofovir disoprovil fumarate HIV prophylaxis linked with minimal kidney impact
Cardiology

Radiofrequency renal denervation produces long-lasting reductions in blood pressure

April 20, 2022
Parental nonmedical prescription opioid use linked to adolescent use
Cardiology

Intensive blood pressure control associated with increased cerebral blood flow in patients with hypertension – the SPRINT trial

March 8, 2022
UTI associated with increased risk of preeclampsia
Cardiology

Isometric exercise training may be more effective  at blood pressure management than high intensity interval training

February 1, 2022
UTI associated with increased risk of preeclampsia
Cardiology

The risk of dementia is associated with being greater at the extremes of systolic blood pressure in adults 75 or older

December 15, 2021
Next Post
MRI helps predict risk of local recurrence in upper rectal cancers

Clinically undetected myocardial scars detected by cardiac MRI

PCI not superior to medical therapy alone in stable coronary disease: The COURAGE study

PCI not superior to medical therapy alone in stable coronary disease: The COURAGE study

Endovascular thrombectomy improves functional outcomes but not mortality in acute ischemic stroke

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • University students perceive that Instagram improves social connection but impairs mental wellbeing
  • 2 Minute Medicine Rewind May 22nd, 2022
  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.